Pacira BioSciences Announces FDA Approval of Expanded Indications for Exparel
Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.
Pharma’s cold chain is going below zero
Cellular and genetic therapies drive a ‘new paradigm’ for logistics
Brand enhancement and safety with unit-dose packaging
Packaging designers continue the uphill battle for converting the US pharma industry to unit-dose, compliance-improving packaging
485 Route 1 South,Building F, Suite 210Iselin, NJ 08830